Taylor Hicks, MD
Vascular Surgery · Katy, TXNPI 1982853750
Payments from drug & device makers
Across 59 payments — averaging $118.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$4K
- Alphatec Spine, Inc$2K
- W. L. Gore & Associates, Inc.$275
- Acera Surgical, Inc.$135
- Endologix LLC$118
- Medtronic$89
- plus $295 from 9 others
What the payments were for
- Speaking & faculty fees$2,05029%
- Travel & lodging$3,03744%
- Food & beverage$1,67024%
- Education$2243%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 35 | $3,918 |
| Alphatec Spine, Inc | 4 | $2,151 |
| W. L. Gore & Associates, Inc. | 3 | $275 |
| Acera Surgical, Inc. | 1 | $135 |
| Endologix LLC | 1 | $118 |
| Medtronic | 4 | $89 |
| Imperative Care, Inc | 1 | $60 |
| Boston Scientific | 1 | $48 |
| Silk Road Medical, Inc. | 1 | $34 |
| Solventum Corporation | 1 | $33 |
| Bard Peripheral Vascular, Inc. | 2 | $29 |
| Lemaitre Vascular, Inc. | 2 | $24 |
| Abbott | 1 | $23 |
| Viiv Healthcare Company | 1 | $22 |
| Insmed, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,982 in reported general payments places this provider in the 45th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $19,903 |
| XareltoRivaroxaban | 19 | $15,470 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 54 | $279 |
| Atorvastatin Calcium | 41 | $228 |
| ClopidogrelClopidogrel Bisulfate | 25 | $183 |
| Simvastatin | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Katy
- Stuart HarlinKaty$100K
- Mazin FotehAustin$2.5M
- Alan LumsdenHouston$2.4M
- Gregory PearlDallas$2.3M
- Gustavo OderichHouston$999K
- Michael SiahDallas$838K
- Stephen HohmannDallas$587K
- Dennis GableDallas$547K
- Carlos TimaranDallas$527K
- Samuel LeonardHouston$431K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.